The UK became the first country in the world to grant emergency approval to a coronavirus vaccine created by the University of Oxford and British-Swedish multinational pharmaceutical company AstraZeneca. The vaccine’s trials had a rocky rollout and haven’t been known for transparency. But the University of Southampton’s Micheal Head tells The World’s Marco Werman that the vaccine’s approval is a game-changer in the fight against the coronavirus pandemic.
The story you just read is not locked behind a paywall because listeners and readers like you generously support our nonprofit newsroom. Now more than ever, we need your help to support our global reporting work and power the future of The World. Can we count on you?